Simoa® Technology
Revolutionizing Biomarker Detection
Quanterix’s Simoa® technology sets a new gold standard for biomarker sensitivity and precision. Detect proteins at femtogram levels in blood, serum, or plasma, enabling earlier disease diagnosis and groundbreaking research. Trusted across neurology, oncology, cardiology, immunology, and infectious disease, Simoa® drives innovation with ultrasensitive instruments, digital immunoassays, and CLIA-certified labs.
Key Features:
- Unmatched sensitivity down to fg/mL levels.
- Accelerates discovery and diagnostics.
- Supports groundbreaking research globally.